What Are The Health Effects Of Consuming Probiotics?

What the research shows

High-quality randomized controlled trials and meta-analyses show that specific probiotic strains such as Bifidobacterium animalis subsp. lactis CNCM I-2494 improve gastrointestinal well-being and reduce digestive symptoms in healthy adults. Probiotics like Escherichia coli Nissle 1917 and Saccharomyces boulardii have demonstrated immune-modulating effects and benefits in infectious diarrhea and immune-compromised states. Probiotics may reduce systemic inflammation markers and improve immune responses in conditions like ulcerative colitis, hepatic encephalopathy, and cystic fibrosis, although evidence quality varies and some findings are preliminary. Meta-analyses indicate probiotics may reduce risk of necrotizing enterocolitis and mortality in very preterm infants. Probiotic supplementation shows potential benefits in mental health, migraine, asthma, and exercise performance, but further high-quality studies are needed. Safety profiles are generally favorable, but adverse events and heterogeneity in study designs limit definitive conclusions. Overall, probiotics can be beneficial for certain populations and conditions, but effects depend on specific strains, doses, and clinical contexts.

Best studied probiotic strains

Who may benefit

Safety

Probiotics are generally safe with few reported adverse events. Some studies report minor side effects such as vomiting, diarrhea, or allergic reactions. No serious safety concerns or sepsis attributable to probiotics were reported in clinical trials. However, critically ill patients may experience increased adverse events, and probiotic use should be cautious in this population. Proper strain identification and dosage are important for safety.

Limitations

Evidence quality varies widely, with many studies having small sample sizes, high risk of bias, or heterogeneity in probiotic strains, doses, and durations. Many findings are preliminary or based on low to moderate quality evidence. Strain-specific effects limit generalizability. More large, high-quality randomized controlled trials are needed to confirm efficacy and safety across different populations and conditions. Some meta-analyses show inconsistent or mixed results. Sponsorship bias may influence reported outcomes in some trials.

PubMed sources